Investment
Features
FeesSafety
Academy
More
Pluang+

Trader Frogman loses $4M in Solana tokens during TOKEN2049 conference in Singapore

Market News
07 Oct 2026
Tokenpost
View Source
Bearish
Trader Frogman loses $4M in Solana tokens during TOKEN2049 conference in Singapore

Trader Frogman lost about $4 million worth of Solana tokens in a suspected wallet drain during the opening morning of the TOKEN2049 crypto conference in Singapore. The tokens were withdrawn at 4:14 a.m. Singapore time and sold in four equal parts within nine minutes. Despite the loss, the trader reported no signs of a breach on his phone or email, highlighting potential security vulnerabilities in crypto wallets. This incident puts a spotlight on the importance of wallet security amid growing crypto events and trading activity.

Trader Frogman’s $4 million Solana wallet drain incident comes as 42 of 50 major cryptocurrencies on Pluang fell on October 7, 2026. For readers following crypto markets, here is Pluang's market snapshot as of Oct 07, 2026 23:32 WIB: CAKE (PancakeSwap) dropped 9.42% to Rp39.403 with 88% buy order activity, SUSHI (SushiSwap) fell 8.16% to Rp4.175 with 65% sell orders, and DOT (Polkadot) declined 8.13% to Rp19.777 with 70% sell orders. Only 6 cryptocurrencies rose that day, indicating broad market weakness.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
2 hours ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
2 hours ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
3 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
4 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App